title: Farnesyltransferase inhibitors: Ras research yields a potential cancer therapeutic.
authors.affiliation: Department of Cancer Research, Merck Research Laboratories, West Point, Pennsylvania 19486.
authors.forename: J B
authors.initials: JB
authors.lastname: Gibbs
authors.forename: A
authors.initials: A
authors.lastname: Oliff
authors.forename: N E
authors.initials: NE
authors.lastname: Kohl
mesh_terms: D019883:Alkyl and Aryl Transferases; D000595:Amino Acid Sequence; D000818:Animals; D002471:Cell Transformation, Neoplastic / Q000378:metabolism; D006801:Humans; D008969:Molecular Sequence Data; D009369:Neoplasms / Q000188:drug therapy*; D015689:Oncogene Protein p21(ras) / Q000378:metabolism*; D017368:Protein Prenylation / Q000502:physiology*; D014166:Transferases / Q000037:antagonists & inhibitors*
chemical_list: D014166:Transferases; D019883:Alkyl and Aryl Transferases; C064911:p21(ras) farnesyl-protein transferase; D015689:Oncogene Protein p21(ras)